Medexus Pharmaceuticals Inc. (TSX:MDP)
Canada · Delayed Price · Currency is CAD 3.940
+0.070 (1.81%)
Apr 10, 2026, 4:00 PM EST
Medexus Pharmaceuticals Employees
Medexus Pharmaceuticals had 91 employees as of March 31, 2025. The number of employees increased by 9 or 10.98% compared to the previous year.
Employees
91
Change (1Y)
9
Growth (1Y)
10.98%
Revenue / Employee
1.50M CAD
Profits / Employee
-4.10K CAD
Market Cap
127.88M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 91 | 9 | 10.98% |
| Mar 31, 2024 | 82 | -16 | -16.33% |
| Mar 31, 2023 | 98 | -2 | -2.00% |
| Mar 31, 2022 | 100 | 76 | 316.67% |
| Mar 31, 2017 | 24 | 2 | 9.09% |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascend Wellness Holdings | 2,300 |
| Planet 13 Holdings | 783 |
| Cannara Biotech | 452 |
| Auxly Cannabis Group | 446 |
| Charlotte's Web Holdings | 112 |
| HLS Therapeutics | 85 |
| Cardiol Therapeutics | 18 |
Medexus Pharmaceuticals News
- 2 months ago - Medexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection - Newsfile Corp
- 2 months ago - Medexus Schedules Third Fiscal Quarter 2026 Conference Call - Newsfile Corp
- 5 months ago - Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Common Shares - Newsfile Corp
- 5 months ago - Medexus Announces US$51.0 million in New Credit Facilities and Intention to Commence Normal Course Issuer Bid, or NCIB, for its Common Shares - Newsfile Corp
- 5 months ago - Medexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection - Newsfile Corp
- 5 months ago - Medexus Schedules Second Fiscal Quarter 2026 Conference Call - Newsfile Corp
- 7 months ago - Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors - Newsfile Corp
- 8 months ago - Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection - Newsfile Corp